All Vaccinology articles – Page 5
-
NewsComprehensive meta-analysis pinpoints what vaccination strategies different countries should adopt
A new paper offers the first comprehensive meta-analysis examining what types of vaccine intervention strategies have the greatest effect, and whether different intervention strategies work better in different countries.
-
NewsNasal COVID-19 vaccine halts transmission
Next-generation Covid vaccines that target the virus’s points of entry — the nose and mouth — may be able to do what traditional shots cannot: contain the spread of respiratory infections and prevent transmission.
-
NewsIncidence of heart attacks and strokes found to be lower after COVID-19 vaccination
A new study involving nearly the whole adult population of England has found that the incidence of heart attacks and strokes was lower after COVID-19 vaccination than before or without vaccination.
-
News‘Russian doll’ packaging could boost drug delivery
Researchers have developed a new technology that lets them create compartments within compartments on the nanoscale, which can mean timing drug release for maximum effect at the site where it’s most needed.
-
NewsDespite risk, many unsure of temperature to heat food to prevent illness
With bird flu virus detected in cow’s milk, U.S. health authorities have warned the public against potential sources of exposure, including drinking raw or unpasteurized milk, and have reiterated a general warning that consuming uncooked or undercooked poultry or beef products can make you sick. Relatively few ...
-
News New initiative launched to advance mRNA vaccine development against human avian influenza (H5N1)
A new project aiming to accelerate the development and accessibility of human avian influenza (H5N1) messenger RNA (mRNA) vaccine candidates for manufacturers in low- and middle-income countries has been launched
-
NewsHIV vaccines tested in PrEPVacc fail to reduce infections
The results of the PrEPVacc HIV vaccine trial conducted in Eastern and Southern Africa, which ran between 2020 and 2024, show that neither of the two experimental vaccine regimens tested reduced HIV infections among the study population.
-
NewsStudy identifies unpredicted immune responses to adenoviral COVID vaccines
Researchers have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, but not to the mRNA vaccines.
-
NewsStudy shows promise for a universal influenza vaccine
New research reveals a promising approach to developing a universal influenza vaccine — a so-called “one and done” vaccine that confers lifetime immunity against an evolving virus.
-
NewsWhite paper explores innovative approaches to vaccine trials and pandemic preparedness
An international consortium of experts has created a white paper on innovative approaches for clinical vaccine research in order to be better prepared for future pandemics.
-
NewsScientists ID ‘unconventional’ new pathway for TB vaccines
Marginal zone B (MZB) cells are a natural response to TB infection which has been long overlooked - and which might be a welcome new target.
-
NewsJessica Kahn named Senior Associate Dean for Clinical and Translational Research at Albert Einstein College of Medicine
After an extensive national search, Jessica Kahn, M.D., M.P.H., has been appointed as the senior associate dean for clinical and translational research and director of the Block Institute for Clinical and Translational Research (ICTR) at Albert Einstein College of Medicine. Source: Cincinnati Children’s Hospital Jessica Kahn, M.D., M.P.H., ...
-
NewsNanoparticle vaccines enhance cross-protection against influenza viruses
To offer cross-protection against diverse influenza virus variants, nanoparticle vaccines can produce pivotal cellular and mucosal immune responses that enhance vaccine efficacy and broaden protection, a new study reveals.
-
NewsScientists discover how to improve vaccine responses to potentially deadly bacterium
Researchers have shown in an animal model that targeting a key suppressive immune molecule (IL-10) during the delivery of a vaccine improves the ability of the vaccine to protect against infection.
-
NewsStudy backs RSV vaccine safety during pregnancy
Vaccinating mothers against respiratory syncytial virus (RSV) during late pregnancy to protect their newborns is not associated with an increased risk of preterm birth or other poor outcomes, according to a new study.
-
NewsResearchers reveals why recombinant BCG induces a stronger and longer-lasting response
Researchers are working on a more potent version of the BCG vaccine that protects against TB. While the conventional immunizer reduced infection by 90% in experiments with mice, the recombinant BCG increased protection rates to 99%.
-
OpinionCholera: vaccination or better infrastructure?
Vibrio cholerae continues to challenge public health systems worldwide. Should we prioritize vaccination or infrastructure improvements?
-
NewsFrom ‘hit to vial’: Discovery and optimization of a promising vaccine adjuvant
Scientists identified a new and promising adjuvant, dubbed PVP-037 - in principle, this compound can be added to any vaccine to enhance its action.
-
NewsMobile phone data helps track pathogen spread and evolution of superbugs
Combining genomic data and human travel patterns over a 14-year period in South Africa reveals key insights into the spread, evolution and resistance patterns of a major bacterium behind pneumonia and meningitis globally.
-
NewsRegular vaccine boosts may help people who are immunocompromised fight Covid-19
New research finds booster doses of bivalent vaccines given every three to six months helps maintain a person’s ability to neutralize multiple SARS-CoV-2 strains, including XBB.1.5.
